Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Doublle Bioproduct
company
About
Doublle Bioproduct focuses on the research and development of anti-tumor drugs.
- 1 - 10
Highlights
Details
- Last Funding Type
- Private Equity（PE）
- Industries
- Biotechnology,Health Care,Medical,Product Research
- Founded date
- May 28, 2001
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Doublle Bioproduct focuses on the research and development of anti-tumor drugs. Doublle Bioproduct has established five new drug research and development functional platforms, including Gene therapy drug industrial production and quality control platform, cell biotherapy research and development and application platform, tumor vaccine and specific immunotherapy product platform, anti-tumor leading macromolecular drug candidate construction, and pharmacodynamics platform.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Doublle Bioproduct has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Sep 25, 2021 from a Private Equity（PE） round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 25, 2021 | Private Equity（PE） | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Doublle Bioproduct is funded by 2 investors.
Kaide Investment
and Guangzhou Nan Yue Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Private Equity（PE） |
|
|
— | Private Equity（PE） |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
